Search

Your search keyword '"Sankaranarayanan, Rengaswamy"' showing total 899 results
Start Over Author "Sankaranarayanan, Rengaswamy"
899 results on '"Sankaranarayanan, Rengaswamy"'

2. Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial

Author

Sharma, Hitt, Parekh, Sameer, Pujari, Pramod, Shewale, Sunil, Desai, Shivani, Bhatla, Neerja, Joshi, Smita, Pimple, Sharmila, Kawade, Anand, Balasubramani, Latha, Thomas, Anitha, Suri, Vanita, Lalwani, Sanjay, Uday, Rajini, Kamath, Veena, Mandal, Ranajit, Rajeswar, A, Peedicayil, Abraham, Poli, Usha Rani, Banerjee, Dipanwita, Sankaranarayanan, Rengaswamy, Basu, Partha, Muwonge, Richard, Gairola, Sunil, Dogar, Vikas, Rao, Harish, and Shaligram, Umesh

Published
2023
Full Text
View/download PDF

3. Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination

Author

Joshi, Smita, Anantharaman, Devasena, Muwonge, Richard, Bhatla, Neerja, Panicker, Gitika, Butt, Julia, Rani Reddy Poli, Usha, Malvi, Sylla G., Esmy, Pulikkottil O., Lucas, Eric, Verma, Yogesh, Shah, Anand, Zomawia, Eric, Pimple, Sharmila, Jayant, Kasturi, Hingmire, Sanjay, Chiwate, Aruna, Divate, Uma, Vashist, Shachi, Mishra, Gauravi, Jadhav, Radhika, Siddiqi, Maqsood, Sankaran, Subha, Pillai Rameshwari Ammal Kannan, Thiraviam, Kartha, Purnima, Shastri, Surendra S., Sauvaget, Catherine, Radhakrishna Pillai, M., Waterboer, Tim, Müller, Martin, Sehr, Peter, Unger, Elizabeth R., Sankaranarayanan, Rengaswamy, and Basu, Partha

Published
2023
Full Text
View/download PDF

4. Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries

Author

Soerjomataram, Isabelle, Cabasag, Citadel, Bardot, Aude, Fidler-Benaoudia, Miranda Marie, Miranda-Filho, Adalberto, Ferlay, Jacques, Parkin, Donald Maxwell, Ranganathan, Rama, Piñeros, Marion, Znaor, Ariana, Mery, Les, Joko-Fru, Yvonne Walburga, Dikshit, Rajesh, Sankaranarayanan, Rengaswamy, Swaminathan, Rajaraman, and Bray, Freddie

Published
2023
Full Text
View/download PDF

5. Impact of HPV vaccination on HPV-related oral infections

Author

Gheit, Tarik, Muwonge, Richard, Lucas, Eric, Galati, Luisa, Anantharaman, Devasena, McKay-Chopin, Sandrine, Malvi, Sylla G, Jayant, Kasturi, Joshi, Smita, Esmy, Pulikkottil O, Pillai, M Radhakrishna, Basu, Partha, Sankaranarayanan, Rengaswamy, and Tommasino, Massimo

Published
2023
Full Text
View/download PDF

9. Accuracy of high-risk HPV DNA PCR, p16(INK4a) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer

Author

Simoens, Cindy, Gheit, Tarik, Ridder, Ruediger, Gorbaslieva, Ivana, Holzinger, Dana, Lucas, Eric, Rehm, Susanne, Vermeulen, Peter, Lammens, Martin, Vanderveken, Olivier M., Kumar, Rekha Vijay, Gangane, Nitin, Caniglia, Alessandro, Maffini, Fausto, Rubio, Maria Belén Lloveras, Anantharaman, Devasena, Chiocca, Susanna, Brennan, Paul, Pillai, Madhavan Radhakrishna, Sankaranarayanan, Rengaswamy, Bogers, Johannes, Pawlita, Michael, Tommasino, Massimo, and Arbyn, Marc

Published
2022
Full Text
View/download PDF

10. Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition.

Author

Jamison, Dean T, Alwan, Ala, Mock, Charles N, Nugent, Rachel, Watkins, David, Adeyi, Olusoji, Anand, Shuchi, Atun, Rifat, Bertozzi, Stefano, Bhutta, Zulfiqar, Binagwaho, Agnes, Black, Robert, Blecher, Mark, Bloom, Barry R, Brouwer, Elizabeth, Bundy, Donald AP, Chisholm, Dan, Cieza, Alarcos, Cullen, Mark, Danforth, Kristen, de Silva, Nilanthi, Debas, Haile T, Donkor, Peter, Dua, Tarun, Fleming, Kenneth A, Gallivan, Mark, Garcia, Patricia J, Gawande, Atul, Gaziano, Thomas, Gelband, Hellen, Glass, Roger, Glassman, Amanda, Gray, Glenda, Habte, Demissie, Holmes, King K, Horton, Susan, Hutton, Guy, Jha, Prabhat, Knaul, Felicia M, Kobusingye, Olive, Krakauer, Eric L, Kruk, Margaret E, Lachmann, Peter, Laxminarayan, Ramanan, Levin, Carol, Looi, Lai Meng, Madhav, Nita, Mahmoud, Adel, Mbanya, Jean Claude, Measham, Anthony, Medina-Mora, María Elena, Medlin, Carol, Mills, Anne, Mills, Jody-Anne, Montoya, Jaime, Norheim, Ole, Olson, Zachary, Omokhodion, Folashade, Oppenheim, Ben, Ord, Toby, Patel, Vikram, Patton, George C, Peabody, John, Prabhakaran, Dorairaj, Qi, Jinyuan, Reynolds, Teri, Ruacan, Sevket, Sankaranarayanan, Rengaswamy, Sepúlveda, Jaime, Skolnik, Richard, Smith, Kirk R, Temmerman, Marleen, Tollman, Stephen, Verguet, Stéphane, Walker, Damian G, Walker, Neff, Wu, Yangfeng, and Zhao, Kun

Subjects
Humans, Health Priorities, Delivery of Health Care, Global Health, Universal Health Insurance, Behavioral and Social Science, Prevention, Generic health relevance, Good Health and Well Being, Medical and Health Sciences, General & Internal Medicine
Abstract

The World Bank is publishing nine volumes of Disease Control Priorities, 3rd edition (DCP3) between 2015 and 2018. Volume 9, Improving Health and Reducing Poverty, summarises the main messages from all the volumes and contains cross-cutting analyses. This Review draws on all nine volumes to convey conclusions. The analysis in DCP3 is built around 21 essential packages that were developed in the nine volumes. Each essential package addresses the concerns of a major professional community (eg, child health or surgery) and contains a mix of intersectoral policies and health-sector interventions. 71 intersectoral prevention policies were identified in total, 29 of which are priorities for early introduction. Interventions within the health sector were grouped onto five platforms (population based, community level, health centre, first-level hospital, and referral hospital). DCP3 defines a model concept of essential universal health coverage (EUHC) with 218 interventions that provides a starting point for country-specific analysis of priorities. Assuming steady-state implementation by 2030, EUHC in lower-middle-income countries would reduce premature deaths by an estimated 4·2 million per year. Estimated total costs prove substantial: about 9·1% of (current) gross national income (GNI) in low-income countries and 5·2% of GNI in lower-middle-income countries. Financing provision of continuing intervention against chronic conditions accounts for about half of estimated incremental costs. For lower-middle-income countries, the mortality reduction from implementing the EUHC can only reach about half the mortality reduction in non-communicable diseases called for by the Sustainable Development Goals. Full achievement will require increased investment or sustained intersectoral action, and actions by finance ministries to tax smoking and polluting emissions and to reduce or eliminate (often large) subsidies on fossil fuels appear of central importance. DCP3 is intended to be a model starting point for analyses at the country level, but country-specific cost structures, epidemiological needs, and national priorities will generally lead to definitions of EUHC that differ from country to country and from the model in this Review. DCP3 is particularly relevant as achievement of EUHC relies increasingly on greater domestic finance, with global developmental assistance in health focusing more on global public goods. In addition to assessing effects on mortality, DCP3 looked at outcomes of EUHC not encompassed by the disability-adjusted life-year metric and related cost-effectiveness analyses. The other objectives included financial protection (potentially better provided upstream by keeping people out of the hospital rather than downstream by paying their hospital bills for them), stillbirths averted, palliative care, contraception, and child physical and intellectual growth. The first 1000 days after conception are highly important for child development, but the next 7000 days are likewise important and often neglected.

Published
2018

11. Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study

Author

Basu, Partha, Malvi, Sylla G, Joshi, Smita, Bhatla, Neerja, Muwonge, Richard, Lucas, Eric, Verma, Yogesh, Esmy, Pulikkottil O, Poli, Usha Rani Reddy, Shah, Anand, Zomawia, Eric, Pimple, Sharmila, Jayant, Kasturi, Hingmire, Sanjay, Chiwate, Aruna, Divate, Uma, Vashist, Shachi, Mishra, Gauravi, Jadhav, Radhika, Siddiqi, Maqsood, Sankaran, Subha, Prabhu, Priya Ramesh, Kannan, Thiraviam Pillai Rameshwari Ammal, Varghese, Rintu, Shastri, Surendra S, Anantharaman, Devasena, Gheit, Tarik, Tommasino, Massimo, Sauvaget, Catherine, Pillai, M Radhakrishna, and Sankaranarayanan, Rengaswamy

Published
2021
Full Text
View/download PDF

12. HPV DNA genotyping, HPV E6*I mRNA detection, and p16INK4a/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study

Author

Herold-Mende, Christel, Dyckhoff, Gerhard, Mosialos, George, Chiesa, Fausto, Tagliabue, Marta, Ansarin, Mohssen, Boeing, Heiner, Castellsagué, Xavier, de Sanjosé, Silvia, Mena, Marisa, Bosch, Francesc Xavier, Alemany, Laia, Esmy, Pulikottil Okkuru, Jayshree, Rudrapatna S., Sabitha, Kortikere S., Shenoy, Ashok M., Vijayakumar, Manavalan, Chiwate, Aruna S., Thorat, Ranjit V., Hublikar, Girish G., Lakshetti, Shashikant S., Nene, Bhagwan M., Kataki, Amal Ch, Kumar Das, Ashok, Sankaran, Subha, Ramadas, Kunnambath, Carreira, Christine, McKay-Chopin, Sandrine, Somanathan, Thara, Zito, Alfredo, Simoens, Cindy, Gorbaslieva, Ivana, Gheit, Tarik, Holzinger, Dana, Lucas, Eric, Ridder, Ruediger, Rehm, Susanne, Vermeulen, Peter, Lammens, Martin, Vanderveken, Olivier M., Kumar, Rekha Vijay, Gangane, Nitin, Caniglia, Alessandro, Maffini, Fausto, Rubio, Maria Belén Lloveras, Anantharaman, Devasena, Chiocca, Susanna, Brennan, Paul, Pillai, Madhavan Radhakrishna, Sankaranarayanan, Rengaswamy, Bogers, Johannes, Pawlita, Michael, Tommasino, Massimo, and Arbyn, Marc

Published
2021
Full Text
View/download PDF

13. Improving access to cancer care among rural populations in India: Development of a validated tool for health system capacity assessment.

Author

Mallafré‐Larrosa, Meritxell, Chandran, Arunah, Oswal, Kunal, Kataria, Ishu, Purushotham, Arnie, Sankaranarayanan, Rengaswamy, Swaminathan, Rajaraman, Rebello, Rohit, Isaac, Rita, Kuriakose, Moni, Sullivan, Richard, Basu, Partha, Venkata Rani, Nandimandalam, Bona, Ashish, Parekh, Hardika, Palaniraja, Sathishrajaa, Prakash, Devu, Kunnambath, Ramadas, Sankaranayanan, Rengaswamy, and Hutchinson, Brian

Subjects
COMMUNITY health services, EARLY detection of cancer, MEDICAL care, CERVIX uteri, MEDICAL screening, RURAL health services
Abstract

Background: Cancer burden in India is rapidly growing, with oral, breast, and uterine cervix being the three most commonly affected sites. It has a catastrophic epidemiological and financial impact on rural communities, the vast majority of whom are socio‐economically disadvantaged. Strengthening the health system is necessary to address challenges in the access and provision of cancer services, thus improving outcomes among vulnerable populations. Objective: To develop, test, and validate a health system capacity assessment (HSCA) tool that evaluates the capacity and readiness for cancer services provision in rural India. Methods: A multi‐method process was pursued to develop a cancer‐specific HSCA tool. Firstly, item generation entailed both a nominal group technique (to identify the health system dimensions to capture) and a rapid review of published and gray literature (to generate items within each of the selected dimensions). Secondly, tool development included the pre‐testing of questionnaires through healthcare facility visits, and item reduction through a series of in‐depth interviews (IDIs) with key local stakeholders. Thirdly, tool validation was performed through expert consensus. Results: A three‐step HSCA multi‐method tool was developed comprising: (a) desk review template, investigating policies and protocols at the state level, (b) facility assessment protocol and checklist, catering to the Indian public healthcare system, and (c) IDI topic guide, targeting policymakers, healthcare workforce, and other relevant stakeholders. Conclusions: The resulting HSCA tool assesses health system capacity, thus contributing to the planning and implementation of context‐appropriate, sustainable, equity‐focused, and integrated early detection interventions for cancer control, especially toward vulnerable populations in rural India and other low‐resource settings. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

15. Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine

Author

Bhatla, Neerja, primary, Muwonge, Richard, additional, Malvi, Sylla G., additional, Joshi, Smita, additional, Poli, Usha Rani Reddy, additional, Lucas, Eric, additional, Esmy, Pulikkottil O., additional, Verma, Yogesh, additional, Shah, Anand, additional, Zomawia, Eric, additional, Pimple, Sharmila, additional, Jayant, Kasturi, additional, Hingmire, Sanjay, additional, Chiwate, Aruna, additional, Vashist, Shachi, additional, Mishra, Gauravi, additional, Jadhav, Radhika, additional, Siddiqi, Maqsood, additional, Anantharaman, Devasena, additional, Panicker, Gitika, additional, Butt, Julia, additional, Sankaran, Subha, additional, Kannan, Thiraviam Pillai Rameshwari Ammal, additional, Varghese, Rintu, additional, Kartha, Purnima, additional, Pillai, M. Radhakrishna, additional, Waterboer, Tim, additional, Müller, Martin, additional, Sehr, Peter, additional, Unger, Elizabeth R., additional, Sankaranarayanan, Rengaswamy, additional, and Basu, Partha, additional

Published
2023
Full Text
View/download PDF

16. Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in India

Author

M de Carvalho, Tiago, primary, Man, Irene, additional, Georges, Damien, additional, Saraswati, Lopamudra Ray, additional, Bhandari, Prince, additional, Kataria, Ishu, additional, Siddiqui, Mariam, additional, Muwonge, Richard, additional, Lucas, Eric, additional, Sankaranarayanan, Rengaswamy, additional, Basu, Partha, additional, Berkhof, Johannes, additional, Bogaards, Johannes A, additional, and Baussano, Iacopo, additional

Published
2023
Full Text
View/download PDF

17. Current status of human papillomavirus vaccination in India's cervical cancer prevention efforts

Author

Sankaranarayanan, Rengaswamy, Basu, Partha, Kaur, Prabhdeep, Bhaskar, Rajesh, Singh, Gurinder Bir, Denzongpa, Phumzay, Grover, Rajesh K, Sebastian, Paul, Saikia, Tapan, Oswal, Kunal, Kanodia, Rishav, Dsouza, Amantia, Mehrotra, Ravi, Rath, Goura Kishor, Jaggi, Viniita, Kashyap, Sundram, Kataria, Ishu, Hariprasad, Roopa, Sasieni, Peter, Bhatla, Neerja, Rajaraman, Preetha, Trimble, Edward L, Swaminathan, Soumya, and Purushotham, Arnie

Published
2019
Full Text
View/download PDF

22. Comprehensive Control of Human Papillomavirus Infections and Related Diseases

Author

Bosch, F Xavier, Broker, Thomas R, Forman, David, Moscicki, Anna-Barbara, Gillison, Maura L, Doorbar, John, Stern, Peter L, Stanley, Margaret, Arbyn, Marc, Poljak, Mario, Cuzick, Jack, Castle, Philip E, Schiller, John T, Markowitz, Lauri E, Fisher, William A, Canfell, Karen, Denny, Lynette A, Franco, Eduardo L, Steben, Marc, Kane, Mark A, Schiffman, Mark, Meijer, Chris JLM, Sankaranarayanan, Rengaswamy, Castellsagué, Xavier, Kim, Jane J, Brotons, Maria, Alemany, Laia, Albero, Ginesa, Diaz, Mireia, de Sanjosé, Silvia, and on behalf of the authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5

Subjects
HIV/AIDS, Clinical Research, Vaccine Related, Prevention, Cancer, Infectious Diseases, Sexually Transmitted Infections, Immunization, HPV and/or Cervical Cancer Vaccines, Cervical Cancer, Prevention of disease and conditions, and promotion of well-being, 3.4 Vaccines, Infection, Good Health and Well Being, HPV, Cervical cancer, Anal cancer, Penile cancer, Vaginal cancer, authors of ICO Monograph Comprehensive Control of HPV Infections and Related Diseases Vaccine Volume 30, Supplement 5, 2012, HPV testing, HPV vaccination, Oropharyngeal cancer, Screening, Vulvar cancer, Biological Sciences, Agricultural and Veterinary Sciences, Medical and Health Sciences, Virology
Abstract

Infection with human papillomavirus (HPV) is recognized as one of the major causes of infection-related cancer worldwide, as well as the causal factor in other diseases. Strong evidence for a causal etiology with HPV has been stated by the International Agency for Research on Cancer for cancers of the cervix uteri, penis, vulva, vagina, anus and oropharynx (including base of the tongue and tonsils). Of the estimated 12.7 million new cancers occurring in 2008 worldwide, 4.8% were attributable to HPV infection, with substantially higher incidence and mortality rates seen in developing versus developed countries. In recent years, we have gained tremendous knowledge about HPVs and their interactions with host cells, tissues and the immune system; have validated and implemented strategies for safe and efficacious prophylactic vaccination against HPV infections; have developed increasingly sensitive and specific molecular diagnostic tools for HPV detection for use in cervical cancer screening; and have substantially increased global awareness of HPV and its many associated diseases in women, men, and children. While these achievements exemplify the success of biomedical research in generating important public health interventions, they also generate new and daunting challenges: costs of HPV prevention and medical care, the implementation of what is technically possible, socio-political resistance to prevention opportunities, and the very wide ranges of national economic capabilities and health care systems. Gains and challenges faced in the quest for comprehensive control of HPV infection and HPV-related cancers and other disease are summarized in this review. The information presented may be viewed in terms of a reframed paradigm of prevention of cervical cancer and other HPV-related diseases that will include strategic combinations of at least four major components: 1) routine introduction of HPV vaccines to women in all countries, 2) extension and simplification of existing screening programs using HPV-based technology, 3) extension of adapted screening programs to developing populations, and 4) consideration of the broader spectrum of cancers and other diseases preventable by HPV vaccination in women, as well as in men. Despite the huge advances already achieved, there must be ongoing efforts including international advocacy to achieve widespread-optimally universal-implementation of HPV prevention strategies in both developed and developing countries. This article summarizes information from the chapters presented in a special ICO Monograph 'Comprehensive Control of HPV Infections and Related Diseases' Vaccine Volume 30, Supplement 5, 2012. Additional details on each subtopic and full information regarding the supporting literature references may be found in the original chapters.

Published
2013

24. Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study

Author

Sankaranarayanan, Rengaswamy, Joshi, Smita, Muwonge, Richard, Esmy, Pulikottil Okkuru, Basu, Partha, Prabhu, Priya, Bhatla, Neerja, Nene, Bhagwan M., Shaw, Janmesh, Poli, Usha Rani Reddy, Verma, Yogesh, Zomawia, Eric, Pimple, Sharmila, Tommasino, Massimo, Pawlita, Michael, Gheit, Tarik, Waterboer, Tim, Sehr, Peter, and Pillai, Madhavan Radhakrishna

Published
2018
Full Text
View/download PDF

25. Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines

Author

Mariz, Filipe Colaço, Bender, Noemi, Anantharaman, Devasena, Basu, Partha, Bhatla, Neerja, Pillai, Madhavan Radhakrisna, Prabhu, Priya R., Sankaranarayanan, Rengaswamy, Eriksson, Tiina, Pawlita, Michael, Prager, Kristina, Sehr, Peter, Waterboer, Tim, Müller, Martin, and Lehtinen, Matti

Published
2020
Full Text
View/download PDF

36. Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition

Author

Gelband, Hellen, Sankaranarayanan, Rengaswamy, Gauvreau, Cindy L, Horton, Susan, Anderson, Benjamin O, Bray, Freddie, Cleary, James, Dare, Anna J, Denny, Lynette, Gospodarowicz, Mary K, Gupta, Sumit, Howard, Scott C, Jaffray, David A, Knaul, Felicia, Levin, Carol, Rabeneck, Linda, Rajaraman, Preetha, Sullivan, Terrence, Trimble, Edward L, and Jha, Prabhat

Published
2016
Full Text
View/download PDF

38. World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2–3 and screen-and-treat strategies to prevent cervical cancer

Author

Santesso, Nancy, Mustafa, Reem A., Schünemann, Holger J., Arbyn, Marc, Blumenthal, Paul D., Cain, Joanna, Chirenje, Michael, Denny, Lynette, De Vuyst, Hugo, Eckert, Linda O’Neal, Forhan, Sara E., Franco, Eduardo L., Gage, Julia C., Garcia, Francisco, Herrero, Rolando, Jeronimo, José, Lu, Enriquito R., Luciani, Silvana, Quek, Swee Chong, Sankaranarayanan, Rengaswamy, Tsu, Vivien, and Broutet, Nathalie

Published
2016
Full Text
View/download PDF

39. Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study

Author

Sankaranarayanan, Rengaswamy, Prabhu, Priya Ramesh, Pawlita, Michael, Gheit, Tarik, Bhatla, Neerja, Muwonge, Richard, Nene, Bhagwan M, Esmy, Pulikottil Okuru, Joshi, Smita, Poli, Usha Rani Reddy, Jivarajani, Parimal, Verma, Yogesh, Zomawia, Eric, Siddiqi, Maqsood, Shastri, Surendra S, Jayant, Kasturi, Malvi, Sylla G, Lucas, Eric, Michel, Angelika, Butt, Julia, Vijayamma, Janki Mohan Babu, Sankaran, Subha, Kannan, Thiraviam Pillai Rameshwari Ammal, Varghese, Rintu, Divate, Uma, Thomas, Shila, Joshi, Geeta, Willhauck-Fleckenstein, Martina, Waterboer, Tim, Müller, Martin, Sehr, Peter, Hingmire, Sanjay, Kriplani, Alka, Mishra, Gauravi, Pimple, Sharmila, Jadhav, Radhika, Sauvaget, Catherine, Tommasino, Massimo, and Pillai, Madhavan Radhakrishna

Published
2016
Full Text
View/download PDF

42. Report from a symposium on catalyzing primary and secondary prevention of cancer in India

Author

Krishnan, Suneeta, Dhillon, Preet K., Bhadelia, Afsan, Schurmann, Anna, Basu, Partha, Bhatla, Neerja, Birur, Praveen, Colaco, Rajeev, Dey, Subhojit, Grover, Surbhi, Gupta, Harmala, Gupta, Rakesh, Gupta, Vandana, Lewis, Megan A., Mehrotra, Ravi, McMikel, Ann, Mukherji, Arnab, Naik, Navami, Nyblade, Laura, Pati, Sanghamitra, Pillai, M. Radhakrishna, Rajaraman, Preetha, Ramesh, Chalurvarayaswamy, Rath, G. K., Reithinger, Richard, Sankaranarayanan, Rengaswamy, Selvam, Jerard, Shanmugam, M. S., Shridhar, Krithiga, Siddiqi, Maqsood, Squiers, Linda, Subramanian, Sujha, Travasso, Sandra M., Verma, Yogesh, Vijayakumar, M., Weiner, Bryan J., Reddy, K. Srinath, and Knaul, Felicia M.

Published
2015

44. Universal Health Coverage and Intersectoral Action for Health

Author

Jamison, Dean T., primary, Alwan, Ala, additional, Mock, Charles N., additional, Nugent, Rachel, additional, Watkins, David A., additional, Adeyi, Olusoji, additional, Anand, Shuchi, additional, Atun, Rifat, additional, Bertozzi, Stefano, additional, Bhutta, Zulfiqar, additional, Binagwaho, Agnes, additional, Black, Robert, additional, Blecher, Mark, additional, Bloom, Barry R., additional, Brouwer, Elizabeth, additional, Bundy, Donald A. P., additional, Chisholm, Dan, additional, Cieza, Alarcos, additional, Cullen, Mark, additional, Danforth, Kristen, additional, de Silva, Nilanthi, additional, Debas, Haile T., additional, Donkor, Peter, additional, Dua, Tarun, additional, Fleming, Kenneth A., additional, Gallivan, Mark, additional, Garcia, Patricia, additional, Gawande, Atul, additional, Gaziano, Thomas, additional, Gelband, Hellen, additional, Glass, Roger, additional, Glassman, Amanda, additional, Gray, Glenda, additional, Habte, Demissie, additional, Holmes, King K., additional, Horton, Susan, additional, Hutton, Guy, additional, Jha, Prabhat, additional, Knaul, Felicia, additional, Kobusingye, Olive, additional, Krakauer, Eric, additional, E. Kruk, Margaret, additional, Lachmann, Peter, additional, Laxminarayan, Ramanan, additional, Levin, Carol, additional, Looi, Lai Meng, additional, Madhav, Nita, additional, Mahmoud, Adel, additional, Mbanya, Jean-Claude, additional, Measham, Anthony R., additional, Medina-Mora, María Elena, additional, Medlin, Carol, additional, Mills, Anne, additional, Mills, Jody-Anne, additional, Montoya, Jaime, additional, Norheim, Ole, additional, Olson, Zachary, additional, Omokhodion, Folashade, additional, Oppenheim, Ben, additional, Ord, Toby, additional, Patel, Vikram, additional, Patton, George C., additional, Peabody, John, additional, Prabhakaran, Dorairaj, additional, Qi, Jinyuan, additional, Reynolds, Teri, additional, Ruacan, Sevket, additional, Sankaranarayanan, Rengaswamy, additional, Sepúlveda, Jaime, additional, Skolnik, Richard, additional, Smith, Kirk R., additional, Temmerman, Marleen, additional, Tollman, Stephen, additional, Verguet, Stéphane, additional, Walker, Damian, additional, Walker, Neff, additional, Wu, Yangfeng, additional, and Zhao, Kun, additional

Published
2017
Full Text
View/download PDF

47. IARC Perspective on Oral Cancer Prevention

Author

Bouvard, Véronique, primary, Nethan, Suzanne T., additional, Singh, Deependra, additional, Warnakulasuriya, Saman, additional, Mehrotra, Ravi, additional, Chaturvedi, Anil K., additional, Chen, Tony Hsiu-Hsi, additional, Ayo-Yusuf, Olalekan A., additional, Gupta, Prakash C., additional, Kerr, Alexander R., additional, Tilakaratne, Wanninayake M., additional, Anantharaman, Devasena, additional, Conway, David I., additional, Gillenwater, Ann, additional, Johnson, Newell W., additional, Kowalski, Luiz P., additional, Leon, Maria E., additional, Mandrik, Olena, additional, Nagao, Toru, additional, Prasad, Vinayak M., additional, Ramadas, Kunnambath, additional, Roitberg, Felipe, additional, Saintigny, Pierre, additional, Sankaranarayanan, Rengaswamy, additional, Santos-Silva, Alan R., additional, Sinha, Dhirendra N., additional, Vatanasapt, Patravoot, additional, Zain, Rosnah B., additional, and Lauby-Secretan, Béatrice, additional

Published
2022
Full Text
View/download PDF

48. Effectiveness of triennial screening with clinical breast examination: 14‐years follow‐up outcomes of randomized clinical trial in Trivandrum, India

Author

Ramadas, Kunnambath, primary, Basu, Partha, additional, Mathew, Beela S., additional, Muwonge, Richard, additional, Venugopal, Muraleedharan, additional, Prakasan, Aparna M., additional, Malu, Rafi, additional, Lucas, Eric, additional, Augustine, Paul, additional, Mony, Rari P., additional, Thara, Somanathan, additional, and Sankaranarayanan, Rengaswamy, additional

Published
2022
Full Text
View/download PDF

50. Implementation of visual inspection with acetic acid and Lugol's iodine for cervical cancer screening in rural China

Author

Hu, Shang‐Ying, primary, Zhao, Xue‐Lian, additional, Zhao, Fang‐Hui, additional, Wei, Li‐Hui, additional, Zhou, Qi, additional, Niyazi, Mayinuer, additional, Liu, Ji‐Hong, additional, Wang, Chun‐Yan, additional, Li, Long‐Yu, additional, Cheng, Xiao‐Dong, additional, Duan, Xian‐Zhi, additional, Sauvaget, Catherine, additional, Qiao, You‐Lin, additional, and Sankaranarayanan, Rengaswamy, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results